BloombergAfinitor (Everolimus) Combo For Breast Cancer Approved By FDAMedical News TodayThe FDA has approved Afinitor (everolimus) in combination with Aromasin (exemestane) for the treatment of some postmenopausal females with advanced hormone-receptor…
Novartis' breast cancer drug, Afinitor receives US FDA approvalpharmabiz.comNovartis has received the US Food and Drug Administration (FDA) approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone r…
FDA Approves Afinitor for Advanced Breast CancerBrevard TimesThe U.S. Food and Drug Administration on Friday approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-re…
FDA Gives Nod to New Breast Cancer DrugPhiladelphia InquirerFRIDAY, July 20 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breas…
Novartis receives FDA approval for Afinitor to treat HER2-negative breast cancerNews-Medical.netThe U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal…
BloombergFDA Approves mTOR Inhibitor Everolimus for Breast CancerOb.Gyn. News Digital NetworkThe approval of everolimus has been expanded to include a group of postmenopausal women with advanced hormone receptor–positive, HER2-negative breast cancer,…
US FDA approves Novartis drug Afinitor for breast cancerReutersThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicin…
FDA approves Afinitor for advanced breast cancerFDA.govThe U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor pos…
BloombergFDA approves Novartis drug Afinitor for breast cancerReuters IndiaThe drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. Afinitor…
Novartis gains FDA approval for Afinitor® in advanced breast cancer marking a …ITNewsThe approval was based on a randomized, double-blind, placebo-controlled, multi- center trial called BOLERO-2 (Breast cancer trials of OraL EveROlimus-2), which eva…